Transient receptor potential vanilliod 1 (TRPV1) channels have recently been postulated to play a role in the vascular complications/consequences associated with diabetes despite the fact that the mechanisms through which TRPV1 regulates vascular function are not fully known. Accordingly, our goal was to define the mechanisms by which TRPV1 channels modulate vascular function and contribute to vascular dysfunction in diabetes. We subjected mice lacking TRPV1 [TRPV1 (Ϫ/ Ϫ)], db/db, and control C57BLKS/J mice to in vivo infusion of the TRPV1 agonist capsaicin or the ␣-adrenergic agonist phenylephrine (PE) to examine the integrated circulatory actions of TRPV1. Capsaicin (1, 10, 20, and 100 g/kg) dose dependently increased MAP in control mice (5.7 Ϯ 1.6, 11.7 Ϯ 2.1, 25.4 Ϯ 3.4, and 51.6 Ϯ 3.9%), which was attenuated in db/db mice (3.4 Ϯ 2.1, 3.9 Ϯ 2.1, 7.0 Ϯ 3.3, and 17.9 Ϯ 6.2%). TRPV1
(Ϫ/
Ϫ)], db/db, and control C57BLKS/J mice to in vivo infusion of the TRPV1 agonist capsaicin or the ␣-adrenergic agonist phenylephrine (PE) to examine the integrated circulatory actions of TRPV1. Capsaicin (1, 10, 20 , and 100 g/kg) dose dependently increased MAP in control mice (5.7 Ϯ 1.6, 11.7 Ϯ 2.1, 25.4 Ϯ 3.4, and 51.6 Ϯ 3.9%), which was attenuated in db/db mice (3.4 Ϯ 2.1, 3.9 Ϯ 2.1, 7.0 Ϯ 3.3, and 17.9 Ϯ 6.2%). TRPV1
(Ϫ/Ϫ) mice exhibited no changes in MAP in response to capsaicin, suggesting the actions of this agonist are specific to TRPV1 activation. Immunoblot analysis revealed decreased aortic TRPV1 protein expression in db/db compared with control mice. Capsaicin-induced responses were recorded following inhibition of endothelin A and B receptors (ET A /ETB). Inhibition of ET A receptors abolished the capsaicin-mediated increases in MAP. Combined antagonism of ET A and ETB receptors did not further inhibit the capsaicin response. Cultured endothelial cell exposure to capsaicin increased endothelin production as shown by an endothelin ELISA assay, which was attenuated by inhibition of TRPV1 or endothelin-converting enzyme. TRPV1 channels contribute to the regulation of vascular reactivity and MAP via production of endothelin and subsequent activation of vascular ET A receptors. Impairment of TRPV1 channel function may contribute to vascular dysfunction in diabetes.
transient receptor potential vanilloid 1 channel; capsaicin THE TRANSIENT RECEPTOR POTENTIAL VANILLOID (TRPV) channels represent one of the known TRP subfamilies and are characteristically gated by chemical and physical stimuli including acid, heat, ethanol, and vanilloid compounds, such as capsaicin, the active component from chili peppers (5) . The TRPV1 channel, a ligand-gated nonselective cation channel, regulates intracellular Ca 2ϩ -homeostasis. TRPV1 channels, primarily expressed in sensory nerves innervating the heart and blood vessels, are known to function as molecular integrators of multiple stimuli, including protons, noxious heat, endovanilloids, as well as numerous endogenous inflammatory mediators (5) . Previous studies (1, 4, 6, 8, 23, 27, 46, 49, 50) from our laboratory and others have revealed the presence of TRP channel expression in vascular smooth muscle cells and endothelial cells, suggesting that these channels may regulate and/or modulate vascular functions. Consistent with these observations, in previous studies from our laboratory (4), we found that TRPV1 channels are involved in the regulation of coronary tone, largely through Ca 2ϩ entry via endothelial TRPV1 channels, triggering nitric oxide (NO)-dependent vasodilation of vascular smooth muscle in conduit coronary arteries from Ossabaw swine. Importantly, TRPV1 signaling was virtually abolished in pigs exhibiting metabolic syndrome and thus could be a potential mechanism contributing to the endothelial dysfunction and the development of vascular dysfunction and coronary disease seen in diabetes.
The above studies point to a pivotal role of the TRPV1 channel in cardiovascular regulation in diabetes, as well as a potential target for novel therapeutic approaches. Despite these compelling observations suggesting an important role of TRPV1 in cardiovascular homeostasis, the integrated circulatory actions of TRPV1 activation are largely unknown.
An association between capsaicin and endothelin has been previously established (20, 30, 31) . Endothelin-1 (ET-1), a peptide of 21 amino acids, is one of the most potent vasoconstrictors known (48) . A major source of endothelin is thought to be the endothelial layer (25) . Endothelins act on ET A and ET B receptors, both being G-protein-coupled receptors, that can activate multiple types of G proteins and influence numerous signaling pathways (2, 36) . The ET A receptor stimulates G proteins of the G q , G s , and G 12/13 families, whereas the ET B receptor activates G proteins of the G q and G i families (3, 14, 28) . ET-1 has been shown to potentiate TRPV1 currents via an ET A /protein kinase C (PKC)-dependent pathway (30, 31) . Similarly, TRPV1 has been shown to contribute to ET-1-induced thermal hyperalgesia (20) .
To expand our in vitro findings to an in vivo model, the goals of the current study were multiple: 1) to examine the systemic hemodynamic effects of the potent and selective TRPV1 agonist, capsaicin, in vivo; 2) to delineate the underlying functional mechanisms; and 3) investigate the hypothesis that vascular dysfunction in diabetes is coupled to impaired contribution of arterial TRPV1 channels. In the present study using control, diabetic (db/db), and TRPV1 null mice (TRPV1 Ϫ/Ϫ ) combined with pharmacological and physiological approaches, we demonstrate that TRPV1 channels directly regulate systemic pressure through an endothelin and ET A receptor pathway. Importantly, we report for the first time that the expression of TRPV1 channels is impaired in diabetes.
METHODS AND MATERIALS
Mice. All procedures were conducted with the approval of the Institutional Animal Care and Use Committee of the Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOMP) and in accordance with National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 1996). Mice breeding pairs were originally purchased from The Jackson Laboratory (Bar Harbor, ME) after which mice were bred in our animal facility at NEOUCOMP. BKS.Cg-m ϩ/ϩ Lepr db /J (db/db) mice have a mutation on chromosome 4 that inhibits the expression of the leptin receptor, whereas heterozygous mice cannot be distinguished from normal mice. The type 2 diabetes mellitus in db/db mice is similar to type 2 diabetes mellitus in adult humans, characterized by obesity, insulin resistance/hyperinsulinemia, and hyperglycemia that the mice develop by 4 -8 wk of age. Experiments were performed in 10-to 12-wk-old male TRPV1 Ϫ/Ϫ , db/db, or control aged-matched, C57BKS/J mice as controls. Mice were housed in a temperaturecontrolled room with a 12:12-h light-dark cycle and maintained with access to food and water ad libitum.
Jugular and femoral artery catheterization and measurement of mouse blood pressure. Mice received a surgical plane of inhaled anesthesia with 1.5-2.5% sevoflurane gas with supplemental oxygen, using a Veterinary Anesthesia and Monitoring device. Animals were placed on controlled heating table, maintained at 37°C with core temperature measured via a rectal probe. Mice were secured in the supine position and placed under a dissecting microscope. The right jugular vein was cannulated with PE-50 polyethylene tubing (BectonDickinson, Oakville, ON) containing 50 U/ml heparine (50 U/ml in Dulbecco's PBS) in saline for intravenous drug infusions. Next, a midline incision was made on the ventral right thigh region and the femoral nerve was isolated and pulled aside. The distal and proximal ends of the femoral artery were held with surgical sutures for temporary control of bleeding, and the distal end of the femoral artery was tied off. The femoral artery was isolated and cannulated with a 1.4-Fr (SPR-1000; Millar Insturments) high-fidelity microtip transducer catheter connected to a data acquisition system (PowerLab ML820; ADInstrument, Colorado Springs, CO) through a pressure interface unit (Transducer Balance, TCB 600; Millar Instruments) designed to measure invasively systolic, diastolic, pulse pressure, mean arterial blood pressure (MAP) and heart rate (HR). The microtip catheter was advanced into the femoral artery, and aortic blood pressure was recorded. All measured variables were continuously recorded and stored on an iMac computer that used the PowerLab system (ADInstruments, Castle Hill, Australia). The blood pressure data were collected and analyzed using AD-instrument Chart v5.1.2 software. To correct HR measurement by the ML820 for movement artifact, an ECG monitor was connected throughout the experiments. All mice were euthanized following the experimental protocol utilizing a lethal dose of pentobarbital sodium (50 g/kg).
Experimental protocol. Following each surgery, mice were given a bolus injection of the ganglion blocker hexamethonium (HEX; 5 mg/kg; Sigma, St. Louis, MO) and initial studies were performed to determine the effects of continuous infusion of phenylephrine (at doses of PE, 2.5 and 5.0 g/kg, iv; Sigma) on MAP. PE was continuously infused for 4 min at a rate of 20 l/min. Capsaicin doses (1-100 g/kg) were administered in an escalating fashion at the rate of 20 l/min for 4 min. The vehicle was 1% DMSO (Sigma) in saline. Vehicle had no effect on MAP. Pressor response curves were performed in control, db/db, and TRPV1 knockout mice before and after inhibition of TRPV1 channels [capsazepine 10 mg/kg iv (Sigma) via bolus injection] or following inhibition of ETA/ETB receptors (FR 139317/IRL-2500, respectively, via bolus injection). Five to ten minutes elapsed following each inhibitor before capsaicin infusion began to allow for MAP to stabilize. Pressures and/or heart rate were continuously recorded throughout the experiment.
Endothelin ELISA assay. Endothelin production measured in response to capsaicin incubation was determined in cultured bovine aortic endothelial cells (BAECs) maintained in low glucose containing DMEM supplemented with L-glutamine and sodium pyruvate (Fisher SH3002102) plus 10% FBS, 1ϫ endothelial cell growth supplement (Sigma E0760), and 1ϫ nonessential amino acid (Sigma M7145). Primary cultures were incubated in a humidified cell incubator (37°C with 5% CO 2 atmosphere) for 24 -48 h before experiments. Cells were pretreated for 30 min with either the TRPV1 inhibitor (SB366791; 10 M) or an endothelin-converting enzyme inhibitor (CGS30566; 30 M) and then exposed to various capsaicin concentrations for 10 min. Following the incubation with capsaicin, the cell culture media were collected and samples were placed into a 96-well ET-1 ELISA plate (Calbiochem) to be analyzed per manufacturer's instructions.
Immunoblots. TRPV1 Western blotting was performed as described previously (4) . Actin staining was performed to determine loading controls.
Drugs. All drugs were purchased from Sigma Chemicals (St. Louis, MO) unless otherwise stated. Capsaicin was dissolved in stock solutions of DMSO. Capsazepine (5 mg/kg) was dissolved in stock solutions of methanol (methanol vehicle had no effect on blood pressure; transient change from baseline: Ϫ1.3 Ϯ 1.1 mmHg). HEX (5 mg/ml) stock solution was made up in saline.
Statistics. The mean of HR and MAP at 30 s before the infusion of drugs was taken as baseline values. The largest value after drug infusion was taken as the maximum (HR or MAP). The percentage of maximal change of HR and MAP was calculated using the formula: percent change (%change) ϭ (maximum Ϫ baseline)/ baseline * 100. Data are expressed as means Ϯ SE. Statistical comparisons were made with paired t-tests or two-way repeated measures ANOVA (with Student-Newman-Keuls multiple comparison) as appropriate. For statistical analyses, GraphPad Prism 4.0 software for Windows XP (GraphPad Software, San Diego, CA) was utilized, and calculation of percentage change was performed using Excel 2007 (Microsoft, Redmond, WA). In all tests, P Ͻ 0.05 was considered significant.
RESULTS
TRPV1 channels directly regulate vascular tone. Phenotypic characteristics of mice are displayed in Table 1 . Body weight was significantly higher in db/db mice (in g): db/db: 52.5 Ϯ 1.7 vs. control: 26.9 Ϯ 0.5 vs. TRPV1KO: 29.0 Ϯ 0.7. In addition, as expected, db/db mice displayed a significantly higher fasting blood glucose concentration (Table 1) . Similarly, baseline HR was significantly increased in db/db mice (446 Ϯ 22 beats/min) and TRPV1 KO (463 Ϯ 12 beats/min) compared with controls (396 Ϯ 11 beats/min); however, following HEX and capsaicin Values are means Ϯ SE. Plasma glucose concentrations were recorded following overnight fasting of initial subset of animals (n ϭ 6 each group). Body weights were recorded before anesthesia [control: n ϭ 37; db/db: n ϭ 21; transient receptor potential vanilloid 1 (TRPV1) knockout (KO): n ϭ 12]. Heart rate and pressure data were taken from animals used to generate Fig. 1C (control: n ϭ 10; TRPV1 KO: n ϭ 6) and Fig. 2A (db/db; n ϭ 6). MAP, mean arterial blood pressure; HEX, hexamethonium; Cap, capsaicin. *P Ͻ 0.05 vs. control.
administration, there were no differences between groups (Table 1). Baseline MAP was originally recorded in mice of all groups before any perturbation. db/db mice were significantly hypertensive compared with control mice (db/db: 90.5 Ϯ 5.0 vs. control: 78.9 Ϯ 2.0 vs. TRPV1 null: 81.3 Ϯ 7.1). To eliminate reflex adjustments and focus on the primary actions of TRPV1 channels, hemodynamic effects were examined in mice after autonomic blockade with HEX. The average change in MAP following HEX administration in control mice was Ϫ4.7 Ϯ 1.6 mmHg. Capsaicin, a specific TRPV1 channel agonist, increased MAP in a dose-dependent manner (Fig. 1 , A and C) in control mice (1 g/kg: 5.7 Ϯ 1.6, 10 g/kg: 11.7 Ϯ 2.1, 20 g/kg: 25.4 Ϯ 3.4, 100 g/kg: 51.6 Ϯ 3.9%, respectively). DMSO, the vehicle for capsaicin, did not change pressure (1.7 Ϯ 1.5 mmHg). Pretreatment with capsazepine (5 mg/kg), a TRPV1 channel antagonist, significantly attenuated capsaicin-induced increases in MAP in control mice (Fig. 1C) , confirming that the response to capsaicin is specifically mediated through TRPV1 channels. Similarly, capsazepine alone did not alter MAP (average change from baseline; 0.8 Ϯ 2.9 mmHg). Next, to further examine the role of TRPV1 channels in the regulation of MAP, we administered capsaicin to TRPV1 null mice. As expected, capsaicin failed to elicit change in MAP at any dose tested in TRPV1 null mice, directly confirming that capsaicin-induced responses in control mice are TRPV1 specific (Fig. 1B) . Importantly, neither DMSO nor capsaicin had any influence on HR, suggesting that TRPV1 channels act predominately on blood vessels rather than heart itself (data not shown).
Capsaicin-induced increases in MAP are attenuated in db/db mice. We next evaluated if TRPV1 channel-mediated pressor effects are altered in db/db mice. Again, HEX had no effect on MAP (Ϫ1.6 Ϯ 2.2 mmHg) from baseline. Similar to control mice, capsaicin increased MAP in a dose-dependent manner in db/db mice ( Fig. 2A) . However, the increase in MAP was significantly blunted in db/db mice ( Fig. 2A) , compared with control mice at all doses tested (db/db vs. lean: 1 g/kg: 3.4 Ϯ 2.1 vs. 5.7 Ϯ 1.6, 10 g/kg: 3.9 Ϯ 2.1 vs. 11.7 Ϯ 2.1, 20 g/kg: 7.0 Ϯ 3.3 vs. 25.4 Ϯ 3.4, and 100 g/kg: 17.9 Ϯ 6.2 vs. 51.6 Ϯ 3.9%, respectively). The TRPV1 antagonist, capsazepine (difference from baseline: Ϫ2.5 Ϯ 1.4 mmHg), attenuated the response to capsaicin, however, to a much lesser extent in db/db mice, suggesting that TRPV1 channel activity is severely compromised in db/db mice (Fig. 2B) . Again, no Responses were recorded before and after TRPV1 channel blockade by capsazepine (5 mg/kg). C: summary data of dose-dependent increases in MAP in control mice (white, n ϭ 10) in response to capsaicin, which was significantly attenuated by the antagonist capsazepine (black, n ϭ 6) at all doses. TRPV1 null mice displayed no changes in MAP at any dose of capsaicin. *P Ͻ 0.05 vs. baseline. #P Ͻ 0.05 vs. control at that concentration. Fig. 2 . Attenuated changes in MAP to capsaicin in db/db mice. A: increases in MAP were attenuated to capsaicin in db/db mice (n ϭ 6) at all concentrations compared with control animals (n ϭ 6). B: summary data of capsaicin-mediated changes in MAP in db/db mice in the presence and absence of capsazepine. Capsazepine had a minimal effect on capsaicin-mediated increases in blood pressure. *P Ͻ 0.05 vs. baseline. #P Ͻ 0.05 vs. control at same concentration. changes in HR were observed in response to capsaicin administration (data not shown).
PE-induced MAP is blunted in TRPV1 null mice.
To determine whether differences in vasoreactivity between normal and diabetic animals accounts for the associated differences in capsaicin response, we next measured MAP in response to the known vasoactive agent PE. PE significantly increased MAP at the doses 2.5 and 5 g/kg in both control (n ϭ 8; 31.1 Ϯ 1.7 and 48.8 Ϯ 4.0, respectively) and db/db mice (n ϭ 6; 28.0 Ϯ 4.8 and 48.6 Ϯ 8.5, respectively). However, the percent change in MAP to PE was not different between control and db/db mice. The PE-induced increase in MAP was significantly attenuated in TRPV1 null mice compared with control and db/db mice (n ϭ 6; 21.4 Ϯ 2.4 and 29.0 Ϯ 5.9, respectively, at 2.5 and 5 g/kg).
TRPV1 expression is decreased in db/db mice. To determine if altered functional expression of the TRPV1 channels could account for the attenuated hemodynamic and pressure responses exhibited in db/db mice, TRPV1 protein expression was examined. Western blot analysis of mouse aortic tissue homogenates demonstrated a ϳ50% decrease in TRPV1 protein expression in db/db mice compared with controls ( Fig. 3) , suggesting that the decrease in capsaicin-mediated MAP in db/db mice may be due, in part, to altered expression of TRPV1 channels.
ET A receptor antagonism blunts the capsaicin-mediated pressor response in vivo. An association between capsaicin and endothelin has been previously established (30, 31) . To delineate the underlying mechanism by which TRPV1 channels influence vascular tone and MAP, pressor responses to capsaicin were determined following an ET A and ET B receptor inhibition. ET A receptor inhibition (change from baseline: Ϫ2.2 Ϯ 2.2 mmHg) significantly blocked the capsaicin-mediated pressor response in control mice at every dose (1 g/kg: 3.6 Ϯ 1.1, 10 g/kg: 1.1 Ϯ 1.0, 20 g/kg: Ϫ0.1 Ϯ 3.0, and 100 g/kg: 14.3 Ϯ 7.1% respectively; Fig. 4A ). ET B receptor inhibition (change from baseline: Ϫ1.5 Ϯ 0.5 mmHg) alone did not potentiate the capsaicin-mediated pressor response in control mice (Fig. 4B) . The combined inhibition of ET A and ET B receptors did not further antagonize the capsaicin-mediated pressor response. Our results suggest that endothelin and subsequent activation of ET A receptors mediate capsaicininduced pressor responses. In db/db mice, ET A inhibition (change from baseline: 3.4 Ϯ 2.6 mmHg) significantly blunted the capsaicin pressor response (Fig. 4C) at the two highest capsaicin doses; however, combined ET A/B inhibition reversed the effects of FR139317. ET B inhibition (change from baseline: 0.5 Ϯ 2.2 mmHg) had no effect on the capsaicin-mediated pressor response (Fig. 4D) .
Capsaicin increases endothelin production in cultured BAECs. To better extrapolate our in vivo data to in vitro conditions, endothelin production was measured in BAECs exposed to capsaicin in vitro. Stimulation of BAECs with capsaicin (10 min per dose) markedly increased endothelin production above baseline in a dose dependent fashion (Fig. 5) . Furthermore, 30-min preincubation of BAECs with either the TRPV1 inhibitor (SB366791; 10 M) or an endothelin-converting enzyme inhibitor (CGS30566; 30 M) significantly decreased the capsaicin-induced ET-1 production.
DISCUSSION
This study was designed to delineate the mechanisms by which TRPV1 channels affect pressor responses in control and diabetic mice. Our major findings include the following: 1) pressor responses induced by capsaicin in control mice; 2) blunted capsaicin pressor responses in db/db mice; 3) reduced capsaicin-induced responses correlate well with diminished aortic TRPV1 protein expression in db/db mice; 4) antagonism of ET A receptors significantly blocked the capsaicin-mediated pressor responses in vivo; and 5) incubation with capsaicin in vitro induced endothelin production in cultured endothelial cells, which was attenuated by TRPV1 or endothelin-converting enzyme inhibition. The experiments presented in this study provide direct evidence for the first time that TRPV1 functions to regulate Fig. 3 . Decreased TRPV1 channel expression in db/db aorta. A: representative immunoblot analysis of TRPV1 channels in aortas from control and db/db. Included is TRPV1 channel expression in control in the presence and absence of the TRPV1 antigenic peptide (AP). Channel expression in every sample was normalized to actin staining to control for protein loading. B: group data (n ϭ 3 control mice; n ϭ 3 db/db mice) are expressed as TRPV1 protein expression normalized to actin expression. *P Ͻ 0.05 vs. control. pressor responses in the systemic circulation via an endothelin/ ET A receptor-mediated pathway.
The effect of capsaicin on blood pressure is controversial, as few studies are available concerning the impact of TRPV1 activation on the modulation of vascular function and blood pressure. Acute or short-term capsaicin administration has mixed effects; it either transiently increases or decreases arterial pressure in humans and rodents (7, 16, 22) . In the present study, pressor effects were examined following hexamethonium administration to eliminate reflex adjustments and focus on the primary actions of capsaicin. Capsaicin infusion induced a significant concentration-dependent pressor effect in control mice, which was markedly attenuated by capsazepine, confirming a role for TRPV1 channels in the regulation of MAP (Fig.  1) . A similar effect was seen in db/db mice, albeit depressed compared with controls (Fig. 2) . In contrast, capsaicin had no effect on MAP or HR in TRPV1 null mice, reinforcing the TRPV1-mediated effects of capsaicin in control and db/db mice. In agreement with our present findings, similar effects to intravenous capsaicin injection have been observed previously in pigs (19) and mice (29) .The observed effects were not due to an altered vasoconstrictor response, as PE responses were not different between db/db and control mice. Interestingly, PE responses were significantly attenuated in TRPV1 KO mice. Although the implications of this are not fully resolved, TRP channel involvement in adrenergic signaling has been previously documented (18, 21, 41, 43, 44) .
A unique outcome of the present study is that long-term diabetes (db/db) caused an attenuation of the capsaicin-induced pressor response in vivo and this directly correlated with reduced vascular TRPV1 expression. The decrease in the capsaicin-induced pressor response was not due to a decreased vasoconstrictor response, as our study demonstrated that the PE-mediated pressor response was not impaired by long-term diabetes. An explanation for the decrease in the capsaicininduced pressor response is a possible reduced expression of endothelial TRPV1. Diabetes has been shown to interfere with TRPV1 expression, as several investigations have found decreased TRPV1 expression in dorsal root ganglion neurons (35) , hearts (40) , and epineurial arterioles (6) obtained from diabetic animals. However, the impact of decreased TRPV1 Fig. 4 . Endothelin A (ETA) receptor antagonism blunts the capsaicin-mediated pressor response in vivo. A: summary data of dosedependent increases in MAP in control mice (white, n ϭ 6) in response to capsaicin which was significantly attenuated by the ETA receptor antagonist FR 139317 (black, n ϭ 5) at all doses. Combined ETA and ETB receptor (IRL2500) inhibition did not further inhibit the capsaicin-mediated affect (n ϭ 5). *P Ͻ 0.05 vs. baseline. B: summary data of dose-dependent increases in MAP in control mice (white, n ϭ 6) in response to capsaicin in the presence and absence of the ETB receptor antagonist IRL2500 (black, n ϭ 6) at all doses. C: summary data of dose-dependent increases in MAP in db/db mice (n ϭ 5) in response to capsaicin which was significantly attenuated by FR139317. Combined ET-A/B receptor inhibition reversed the response of ETA receptor inhibition alone (n ϭ 5). D: summary data of dose-dependent increases in MAP in db/db mice (n ϭ 5) in response to capsaicin in the presence and absence of the ETB receptor antagonist IRL2500. *P Ͻ 0.05 vs. control at same concentration. channel expression on the diabetic heart and vasculature has not been thoroughly investigated. In the present study, TRPV1 expression in diabetic mouse aortas was markedly reduced compared with nondiabetic aortas (Fig. 3) , thus providing a mechanism to explain the attenuated responses in db/db mice. TRPV1 channel involvement in the modulation of vascular tone has been previously documented (2, 8, 18) ; however, limited knowledge exists regarding the key cellular mechanisms involved in the modulation of vascular tone observed following TRPV1 stimulation. Whereas capsaicin has been shown to cause vasodilatation in various vascular beds including mesenteric, hepatic, basilar, dural, and meningeal arterioles (1, 8, 17, 27, 34, 51) , our data indicate that capsaicin-induced vasoconstriction may be responsible for modulation of vascular tone under physiological and/or pathophysiological conditions. In fact, capsaicin-induced vasoconstriction was revealed in canine arteries (45) and the canine tracheal vascular bed (37) , suggesting a nonneural capsaicin mode of action. Likewise, previous studies have proposed that TRPV1 activation leads to vasoconstriction in mesenteric (33, 39) , coronary (42) , skeletal muscle (23) , and dural vessels (8) , although the underlying mechanism(s) were not investigated.
The current study is the first demonstration that endothelin is the vasoactive component responsible for the increased MAP response following capsaicin administration. In the systemic vasculature, ET-1 has several effects including potent vasoconstriction (20) and inflammation, which are largely mediated by ET A receptor on vascular smooth muscle cells (24, 38) . Countering those effects are NO production and vasodilation mediated primarily via endothelial ET B receptor (26, 38) . Several studies (20, 30, 31) have demonstrated an interaction between ET-1/ET A and TRPV1 channels, mostly involving ET-1-induced potentiation of TRPV1 channels via an ET A receptormediated activation of PKC. Similarly, capsaicin has been shown to stimulate endothelin release in rat hearts as well as prevent the manifestation of the increased coronary flow and positive inotropic effect mediated by the release of calcitonin gene-related peptide or NO (10 -13, 42) . Herein, we report for the first time that in vivo infusion of capsaicin elicits a pressor response involving ET A receptor activation, as demonstrated by blockade of capsaicin-induced pressor effects in response to ET A receptor inhibition in control animals (Fig. 4) . Importantly, dual ET A/B receptor inhibition did not further inhibit the response to capsaicin compared with ET A inhibition alone. Furthermore, ET B receptor inhibition did not potentiate the capsaicin-mediated pressor response. To extrapolate our in vivo findings to an in vitro setting and to evaluate a direct effect on endothelial cells, the effects of capsaicin on ET-1 production in cultured endothelial cells were tested, which revealed a dose-dependent, capsaicin-induced production of endothelin (Fig. 5) . Although we cannot rule out direct effects of capsaicin on smooth muscle cells, our study clearly demonstrates that antagonists for ET A receptors blunt the capsaicinmediated pressor response in vivo and capsaicin in vitro significantly increased endothelin production in cultured endothelial cells. These results provide strong support for a role for ET-1/ET A receptors in the capsaicin-mediated pressor response. Although not examined in the present study, the role of vasoactive components such as substance P, neurokinin A, and neuropeptide Y cannot be completely ruled out. In fact, Davidson et al. (6) found neuropeptide Y was responsible for the capsaicin-induced vasoconstriction in epineural arterioles of the sciatic nerve. Similarly, release of substance P and neurokinin A (albeit from capsaicin nerve terminals) has been reported to cause vasoconstriction (15) . Other studies have implicated these players; however, this is not the case in the current study, as ET A receptor inhibition markedly attenuated the capsaicin-mediated pressor response. Lastly, a possible complicating factor is the duration of the capsaicin-mediated pressor response. As demonstrated previously, an ET-1-mediated pressor response is typically long lasting (32, 47) . However, in the current study, several other mitigating factors should be taken into consideration, such as production of other endothelial vasoactive (vasodilatory) factors in response to the calcium influx following TRPV1 activation. In addition, the rate of ET-1 clearance by neutral endopeptidase could contribute to this effect (9) . Lastly, the levels of ET-1 produced by capsaicin may not be sufficient to induce the similar longlasting response typically shown by direct injection of ET-1 (32, 47) . All these contributing factors may explain the transient pressor response.
In summary, these studies demonstrate that capsaicin causes a concentration-dependent systemic pressor response in vivo. The capsaicin-induced response was likely due to the release of ET-1 from vascular endothelial cells resulting in activation of ET A receptors on the smooth muscle plasma membrane. Furthermore, long-term diabetes caused a decrease in the capsaicin-induced response that was likely due to decreased aortic endothelial expression of TRPV1. Overall, we report for the first time that TRPV1 activation leads to vascular modulation pressor responses via an endothelin/ET A -mediated pathway. These results suggest a potential physiological/pharmacological role for TRPV1, which in turn represents a promising new therapeutic strategy to control pressor responses as well as tissue-specific blood distribution. Our findings support the hypothesis that vascular dysfunction in diabetes is related to a decrease in vascular TRPV1 channel expression and that diminished TRPV1 channel function is accompanied by a decrease in capsaicin-mediated vasoreactivity and altered vascular regulation. We believe that this impairment of TRPV1 channels could contribute to vascular dysfunction and sensitization of key vasoconstrictor pathways as well as diminished functional hyperemia, typically observed in diabetic subjects.
